Use of NPSP558 in the Treatment of Hypoparathyroidism

NCT00732615 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoparathyroidism

Interventions

DRUG: Placebo
DRUG: NPSP558

Sponsor

Shire